Prana Therapies
Encinitas, US · Founded 2024 · Delaware corporation
Founders & leadership
MS
Miguel SanjuaninExecutive
SG
BA
Ben AuspitzNamed on SEC filing
AB
Alexis BorisyNamed on SEC filing
SG
Sheila Gujrathi, M.D.Named on SEC filing
HO
Hector OrtegaNamed on SEC filing
RS
Ryan SullivanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$45.2M disclosed across 2 rounds · 2024–2025
▶$40.2MraisedAug 2026 · 9 investors · BiotechnologyRule 506(b)
▶$40.2MraisedAug 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ben AuspitzDirector
- Alexis BorisyDirector
- Sheila Gujrathi, M.D.Executive Officer, Director
- Hector OrtegaExecutive Officer
- Ryan SullivanExecutive Officer
- Offering amount
- $40.2M
- Amount sold
- $40.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5MraisedJul 2024 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel SanjuanExecutive Officer, Director
- Sheila GujrathiExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $5M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Prana Therapies raised?
- Prana Therapies has disclosed $45.2M raised across 2 rounds.
- Where is Prana Therapies headquartered?
- Prana Therapies is headquartered in Encinitas, US.